MabGenesis

Italy
Filecchio, Tuscany, Italy, 222-0033

Company profile

MabGenesis company profile

MabGenesis is a biopharmaceutical company that provides therapeutic monoclonal antibody drugs in the human and animal fields. They have an antibody library and monoclonal antibody isolation technology. With the provision of novel antibody therapeutics, the firm helps to relieve symptoms and improve the quality of life of individuals suffering from.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2019-06-03

Headquarters

Postal code
222-0033
Country code
IT
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$5.6M
Last funding
Series Unknown / $3M / 2024-12-24
Last equity funding
Series Unknown / $3M
Investors
7
Lead investors
1
Founders
1
Articles
3

Founders and investors

Founders

Katsuhiro Shinjo

Lead investors

Beyond Next Ventures

Investors

ANNIVERSAIREAxil CapitalBeyond Next VenturesMiyazaki Taiyo CapitalSMBC Venture Capital